ArticleRespiratory medicine case reports2025
Community-acquired pneumonia caused by Kluyvera intermedia: A rare case report.
Article in Respiratory medicine case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 1 synthesis or guideline pooled it.
- <italic>Kluyvera</italic> Infections in Humans: A Systematic Review.Medical principles and practice : international journal of the Kuwait University, Health Science Centre · 2026Pooled it
- Reporting two novelFrontiers in microbiology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Kluyvera intermedia is a rare Gram-negative bacillus that predominantly functions as an opportunistic pathogen. Commonly found in environmental sources such as freshwater and soil, it has been infrequently reported in human infections, often leading to underrecognition in clinical practice. Because it can resemble more prevalent pathogens, accurate identification is crucial for effective management of infections. Case report: We report a case of pneumonia caused by Kluyvera intermedia in a 55-year-old male with a 10-year history of well-controlled hypertension. The patient initially presented with classic pneumonia symptoms, including fever, cough, and right-sided chest pain. Although he received empirical treatment with Cefotaxime Sodium and Levofloxacin at the local hospital, follow-up CT scans revealed further enlargement of the pulmonary lesions. To investigate the underlying etiology, the patient underwent MRI-guided lung biopsy at our hospital, and culture of the aspirated fluid identified Kluyvera intermedia as the causative pathogen. He was subsequently treated with Ceftizoxime sodium and Levonidazole Sodium Chloride Injection, resulting in significant clinical improvement. The patient was discharged after 22 days of hospitalization. Conclusion: Further accumulation and reporting of cases will enhance the recognition of the clinical characteristics of Kluyvera intermedia. These studies will not only expand our understanding of this rare pathogen but also provide a foundation for improved response strategies, thereby ensuring better management of similar infections in future clinical practice.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.